Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

424 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gestational Diabetes Is Characterized by Decreased Medium-Chain Acylcarnitines and Elevated Purine Degradation Metabolites across Pregnancy: A Case-Control Time-Course Analysis.
Heath H, Rosario R, McMichael LE, Fanter R, Alarcon N, Quintana-Diaz A, Pilolla K, Schaffner A, Jelalian E, Wing RR, Brito A, Phelan S, La Frano MR. Heath H, et al. Among authors: phelan s. J Proteome Res. 2023 Jun 2;22(6):1603-1613. doi: 10.1021/acs.jproteome.2c00430. Epub 2023 May 2. J Proteome Res. 2023. PMID: 37129248 Free PMC article.
Metabolites involved in purine degradation, insulin resistance, and fatty acid oxidation are associated with prediction of Gestational diabetes in plasma.
McMichael LE, Heath H, Johnson CM, Fanter R, Alarcon N, Quintana-Diaz A, Pilolla K, Schaffner A, Jelalian E, Wing RR, Brito A, Phelan S, La Frano MR. McMichael LE, et al. Among authors: phelan s. Metabolomics. 2021 Nov 27;17(12):105. doi: 10.1007/s11306-021-01857-5. Metabolomics. 2021. PMID: 34837546 Free PMC article.
Correction to: Metabolites involved in purine degradation, insulin resistance, and fatty acid oxidation are associated with prediction of Gestational diabetes in plasma.
McMichael LE, Heath H, Johnson CM, Fanter R, Alarcon N, Quintana-Diaz A, Pilolla K, Schaffner A, Jelalian E, Wing RR, Brito A, Phelan S, La Frano MR. McMichael LE, et al. Among authors: phelan s. Metabolomics. 2021 Dec 19;18(1):4. doi: 10.1007/s11306-021-01863-7. Metabolomics. 2021. PMID: 34923607 No abstract available.
Practitioner advice and gestational weight gain.
Phelan S, Phipps MG, Abrams B, Darroch F, Schaffner A, Wing RR. Phelan S, et al. J Womens Health (Larchmt). 2011 Apr;20(4):585-91. doi: 10.1089/jwh.2010.2316. Epub 2011 Mar 17. J Womens Health (Larchmt). 2011. PMID: 21413898 Free PMC article. Clinical Trial.
Randomized controlled clinical trial of behavioral lifestyle intervention with partial meal replacement to reduce excessive gestational weight gain.
Phelan S, Wing RR, Brannen A, McHugh A, Hagobian TA, Schaffner A, Jelalian E, Hart CN, Scholl TO, Munoz-Christian K, Yin E, Phipps MG, Keadle S, Abrams B. Phelan S, et al. Am J Clin Nutr. 2018 Feb 1;107(2):183-194. doi: 10.1093/ajcn/nqx043. Am J Clin Nutr. 2018. PMID: 29529157 Free PMC article. Clinical Trial.
424 results